Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Emerging Nanotechnology for the Treatment of Alzheimer's Disease

Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R, Maheshwari S, Shariq M, Parveen S, Shamim A.

CNS Neurol Disord Drug Targets. 2024;23(6):687-696. doi: 10.2174/1871527322666230501232815.

Cholinergic Transporters Serve as Potential Targets in Alzheimer's Disease

Bist R, Bhatt DK.

Curr Mol Med. 2024;24(4):397-398. doi: 10.2174/1566524023666230505155302.

Is There a Role of Vitamin D in Alzheimer's Disease?

Plantone D, Pardini M, Caneva S, De Stefano N.

CNS Neurol Disord Drug Targets. 2024;23(5):545-553. doi: 10.2174/1871527322666230526164421.

Targeting Cellular Senescence: A Potential Therapeutic approach for Alzheimer's Disease

Singh S, Bhatt LK.

Curr Mol Pharmacol. 2024;17:e010623217543. doi: 10.2174/1874467217666230601113430.

New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives

De Marchi F, Vignaroli F, Mazzini L, Comi C, Tondo G.

CNS Neurol Disord Drug Targets. 2024;23(5):614-627. doi: 10.2174/1871527322666230608110201.

Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease

Chen J, Chen JS, Li S, Zhang F, Deng J, Zeng LH, Tan J.

Aging Dis. 2024 Feb 1;15(1):201-225. doi: 10.14336/AD.2023.0308.

Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease

Singh S, Agrawal N, Goyal A.

CNS Neurol Disord Drug Targets. 2024;23(3):384-394. doi: 10.2174/1871527322666230627123426.

Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses

Nasb M, Tao W, Chen N.

Aging Dis. 2024 Feb 1;15(1):43-73. doi: 10.14336/AD.2023.0608.

Aducanumab in Alzheimer's Disease: A Critical Update

Ashique S, Sirohi E, Kumar S, Rihan M, Mishra N, Bhatt S, Gautam RK, Singh SK, Gupta G, Chellappan DK, Dua K.

Curr Med Chem. 2024;31(31):5004-5026. doi: 10.2174/0929867331666230727103553.

Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review

Singh A, Kumar Singh N.

Curr Pharm Biotechnol. 2024;25(9):1112-1123. doi: 10.2174/1389201024666230801095526.

Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease

Qaiser H, Uzair M, Al-Regaiey K, Rafiq S, Arshad M, Yoo WK, Arain OZ, Kaleem I, Abualait T, Wang L, Wang R, Bashir S.

J Alzheimers Dis. 2024;99(s1):S97-S108. doi: 10.3233/JAD-230394.

The Role of Glial Cells in Synaptic Dysfunction: Insights into Alzheimer's Disease Mechanisms

Yu Y, Chen R, Mao K, Deng M, Li Z.

Aging Dis. 2024 Apr 1;15(2):459-479. doi: 10.14336/AD.2023.0718.

Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities

Huang Z, Jordan JD, Zhang Q.

Aging Dis. 2024 Apr 1;15(2):698-713. doi: 10.14336/AD.2023.0628.

The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase

Mamelak M.

J Alzheimers Dis. 2024;99(s1):S109-S118. doi: 10.3233/JAD-230415.

Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease

Sose PM, Kale PP, Doshi GM.

CNS Neurol Disord Drug Targets. 2024;23(8):956-970. doi: 10.2174/1871527323666230904150841.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias